Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell CarcinomaEileen Shiuan, Kathryn E. Beckermann, Anupama Reddy et al.|Cancers|2021Cited by 16
Abstract 310: Immunophenotyping tumors by novel multiplex immunofluorescence and AQUA (Automated Quantitative Analyses) algorithms to guide development of immunotherapiesJu Young Kim, Jennifer Bordeaux, John A. H. Hoerter et al.|Cancer Research|2020Cited by 0
74 Novel approach for profiling immune-tumor cell interactions and mutations in the same tumor section by multiplex immunohistochemistry and NGS in immuno-oncology trialsNathan Riccitelli, Naveen Dakappagari, Jennifer Bordeaux et al.|Regular and Young Investigator Award Abstracts|2020Cited by 0
47 Pathologists enhance interpretation of automated multiplex immunohistochemistry assays in cancer immunotherapy trialsEmmanuel Pacia, Naveen Dakappagari, Xun Li et al.|Regular and Young Investigator Award Abstracts|2020Cited by 0
Abstract 4050: Molecular characterization of residual triple-negative breast cancers after neoadjuvant chemotherapy identifies immune composition and features associated with clinical outcomeCaroline A. Nebhan, Justin M. Balko, Paula I. González-Ericsson et al.|Cancer Research|2019Cited by 0